138 related articles for article (PubMed ID: 25207631)
21. Challenging gene patents. Myriad ruling will impact personalized medicine.
Lee J
Mod Healthc; 2013 Apr; 43(15):8-9. PubMed ID: 23738477
[No Abstract] [Full Text] [Related]
22. Patent medicine.
Baker D
J Public Health Policy; 2001; 22(3):275-9. PubMed ID: 11603309
[No Abstract] [Full Text] [Related]
23. Gene patent policy: does issuing gene patents accord with the purposes of the U.S. patent system?
Bradshaw J
Willamette Law Rev; 2001; 37(4):637-60. PubMed ID: 12774776
[No Abstract] [Full Text] [Related]
24. Strategies for stem cell patent applications in the light of recent court cases.
Eyre DE; Schlich GW
Pharm Pat Anal; 2015; 4(6):431-41. PubMed ID: 26580992
[TBL] [Abstract][Full Text] [Related]
25. Patent protection for Aspergillus-related inventions.
Jong SC; Birmingham JM
Biotechnology; 1992; 23():297-311. PubMed ID: 1504603
[TBL] [Abstract][Full Text] [Related]
26. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
Bergin C
Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
[TBL] [Abstract][Full Text] [Related]
27. Patents. U.S. appeals court hears gene patent arguments.
Marshall E
Science; 2012 Jul; 337(6092):277-8. PubMed ID: 22822118
[No Abstract] [Full Text] [Related]
28. Patent watch: post-approval testing shielded from patent infringement.
Harrison C
Nat Rev Drug Discov; 2012 Sep; 11(9):666. PubMed ID: 23097768
[No Abstract] [Full Text] [Related]
29. Patent prosecution of biotechnology and pharmaceutical patents in a changing legal landscape.
Lu DL; Kowalski TJ; Jarecki-Black J
Future Med Chem; 2010 Jan; 2(1):7-9. PubMed ID: 21426040
[No Abstract] [Full Text] [Related]
30. The end of DNA patents in the United States?
Webber P
Expert Opin Ther Pat; 2013 Dec; 23(12):1525-7. PubMed ID: 24138004
[TBL] [Abstract][Full Text] [Related]
31. Drug development and patent law.
Nusbaum NJ
N Y State J Med; 1992 Mar; 92(3):86-7. PubMed ID: 1557205
[No Abstract] [Full Text] [Related]
32. Patent infringement. Court denies motion to alter patent claim decision.
AIDS Policy Law; 2003 Dec; 18(22):6. PubMed ID: 14974399
[No Abstract] [Full Text] [Related]
33. NIH files counter-patent in breast cancer gene dispute.
Nature; 1994 Nov; 372(6502):118. PubMed ID: 7969430
[No Abstract] [Full Text] [Related]
34. Bioanalysis for precision medicine.
Yang S; Yang Z; Wang PG
Bioanalysis; 2019 Jun; 11(11):1039-1043. PubMed ID: 31251103
[No Abstract] [Full Text] [Related]
35. Patent watch: Have the biosimilar floodgates been opened in the United States?
Brinckerhoff CC; Schorr K
Nat Rev Drug Discov; 2015 May; 14(5):303-4. PubMed ID: 25924576
[No Abstract] [Full Text] [Related]
36. Implications of United States patent laws on the advancement of vascular surgery.
Mousa AY; Broce M
Vascular; 2015 Apr; 23(2):221. PubMed ID: 25646021
[No Abstract] [Full Text] [Related]
37. Intellectual property in higher life forms: the patent system and controversial technologies.
Merges RP
MD Law Rev; 1988; 47(4):1051-75. PubMed ID: 16514761
[No Abstract] [Full Text] [Related]
38. Patent watch: Progress in three key patent disputes in 2009.
Nat Rev Drug Discov; 2010 Jan; 9(1):12-3. PubMed ID: 20050395
[No Abstract] [Full Text] [Related]
39. ACOG. Committee opinion: number 277, November 2002. Patients, medicine and the interests of patients: applying general principles to gene patenting.
Comittee on Ethics, Comittee on Genetics, The American College of Obstetrician and Gynecologists
Obstet Gynecol; 2002 Nov; 100(5 Pt 1):1051-6. PubMed ID: 12434779
[TBL] [Abstract][Full Text] [Related]
40. Use patents, carve-outs, and incentives--a new battle in the drug-patent wars.
Rai A
N Engl J Med; 2012 Aug; 367(6):491-3. PubMed ID: 22873529
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
